Misuse of common antibiotic is creating resistant TB
(American Thoracic Society) Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis. Fluoroquinolones are the most commonly prescribed class of antibiotics in the US and are used to fight a number of different infections such as sinusitis and pneumonia. They are also an effective first line of defense against TB infections that show drug resistance. New research shows, however, that widespread general use of fluoroquinolones may be creating a strain of fluoroquinolone-resistant TB.
source : www.eurekalert.org
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Related News:
- European Medicines Agency Makes Recommendations To Minimise Risk Of…
- Breast Enhancement Surgeon on Long Island Nominated a "Best Of"
- $16 Million Grant From State Stem Cell Agency To Speed Research Of…
- Book and Media Reviews: American Psychiatric Publishing Textbook of…
- After Mastectomy: Making a Decision About Breast Reconstruction
- Robotic Surgery Expert Dr. David B. Samadi Discusses The Benefits Of…
- UM Doctor To Lead Clinical Trial For ALS
- Migraine as inspiration
- Impax Pharmaceuticals Reports Positive Results of Phase II Trial of…
- Analysis of TB treatment studies identifies gaps in guidelines
Details :
Submited at Monday, August 10th, 2009 at 4:01 pm on Infectious Disease by samantha
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















